Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 55 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Abrocitinib for moderate to severe atopic dermatitis	Abrocitinib (PF-04965842)	Atopic dermatitis	Dermatology	2020	View \| Download
Apremilast for treating moderate to severe plaque psoriasis in children and young people	Apremilast (Otezla; CC-10004)	Plaque psoriasis	Dermatology	2023	View \| Download
Baricitinib for moderate to severe atopic dermatitis	Baricitinib (LY3009104; Olumiant) , Corticosteroids	Atopic dermatitis	Dermatology	2019	View \| Download
Baricitinib for treating atopic dermatitis in children and adolescents	Baricitinib (LY3009104; Olumiant)	Atopic dermatitis	Dermatology	2022	View \| Download
Baricitinib for treatment of severe alopecia areata in adults	Baricitinib (LY3009104; Olumiant)	Alopecia areata	Dermatology , Immunology	2021	View \| Download
Beremagene geperpavec for dystrophic epidermolysis bullosa	Bercolagene telserpavec (Beremagene geperpavec; KB103)	Dystrophic epidermolysis bullosa (DEB)	Dermatology	2021	View \| Download
Bimekizumab for active psoriatic arthritis	Bimekizumab (UCB4940)	Psoriatic arthritis	Dermatology , Rheumatology	2021	View \| Download
Bimekizumab for Hidradenitis Suppurativa	Bimekizumab (UCB4940)	Hidradenitis suppurativa (HS)	Dermatology	2022	View \| Download
Bimekizumab for moderate to severe chronic plaque psoriasis	Bimekizumab (UCB4940)	Plaque psoriasis	Dermatology	2019	View \| Download
BMS-986165 for moderate to severe plaque psoriasis	Deucravacitinib (BMS-986165)	Plaque psoriasis	Dermatology	2020	View \| Download